Chapter 10. Radiocontrast Nephropathy

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Brendan J. Barrett MBBS, PhD and
  2. Patrick S. Parfrey MD

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch10

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Barrett, B. J. and Parfrey, P. S. (2008) Radiocontrast Nephropathy, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch10

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Division of Nephrology and Clinical Epidemiology, Faculty of Medicine, Memorial University of Newfoundland St. John's, Newfoundland, Canada

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • radiocontrast nephropathy;
  • risk stratification of patients;
  • preventive interventions;
  • contrast media - osmolality, viscosity, and ionicity;
  • NAC reducing nephrotoxicity of contrast through antioxidant and vasodilatory effects;
  • prophylactic renal replacement therapy;
  • recommendations to reduce risks for CIN


This chapter contains sections titled:

  • Introduction

  • Definition of contrast-induced nephropathy

  • Burden of disease

  • Risk stratification of patients

  • Preventive interventions

  • Conclusions and recommendations

  • References